COVID-19 Vaccine Associated Axillary Adenopathy

Peer-Reviewed Scientific papers regarding COVID-19 Vaccine Associated Axillary Adenopathy

COVID-19 vaccine-induced axillary and pectoral lymphadenopathy in PET

Evolution of bilateral hypermetabolic axillary hypermetabolic lymphadenopathy on FDG PET/CT after 2-dose COVID-19 vaccination

COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: case series with literature review.

Subclinical axillary lymphadenopathy associated with COVID-19 vaccination on screening mammography

Axillary adenopathy associated with COVID-19 vaccination: imaging findings and follow-up recommendations in 23 women

Unilateral axillary adenopathy in the setting of COVID-19 vaccination: follow-up

COVID-19 vaccine-related axillary and cervical lymphadenopathy in patients with current or previous breast cancer and other malignancies: cross-sectional imaging findings on MRI, CT and PET-CT

Incidence of axillary adenopathy on breast imaging after vaccination with COVID-19.

Unilateral axillary lymphadenopathy related to COVID-19 vaccine: pattern on screening breast MRI allowing benign evaluation

Axillary lymphadenopathy in patients with recent Covid-19 vaccination: a new diagnostic dilemma.

COVID-19 vaccine-induced unilateral axillary adenopathy: follow-up evaluation in the USA.

Axillary adenopathy associated with COVID-19 vaccination: imaging findings and follow-up recommendations in 23 women

Unilateral axillary adenopathy in the setting of COVID-19 vaccination: follow-up

Incidence of axillary adenopathy on breast imaging after vaccination with COVID-19.

Unilateral axillary lymphadenopathy related to COVID-19 vaccine: pattern on screening breast MRI allowing benign evaluation

Axillary lymphadenopathy in patients with recent Covid-19 vaccination: a new diagnostic dilemma.

COVID-19 vaccine-induced unilateral axillary adenopathy: follow-up evaluation in the USA.

Adenopathy after COVID-19 vaccination

Back to top